premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly As one of Canada's largest financial and insurance providers, we again reiterate MFC as a TOP PICK. Recently reported earnings missed expectations, due to higher than expected mortality rates in the US due to COVID. However, moving forward the company recently de-risked a sizable portion of their US annuity business that frees up over $2 billion in capital. Higher interest rates will also benefit the company. It trades at only 5x earnings, supports a ROE over 18% and is valued just under book. It pays a healthy dividend, backed by a payout ratio under 30%. We continue to recommend a stop loss at $21.50, looking to achieve $28 -- upside potential over 18%. Yield 5.6% (Analysts’ price target is $27.67)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly We reiterate this regional bank, who is growing market share in key markets in the Southeast, West Coast and Chicago and is expanding its presence with an effective fintech platform strategy. Recently reported earnings indicated growth in both loans and deposits. We like that cash reserves are remaining steady, while the company aggressively retires debt and buys back stock. The company has increased dividends for 11 consecutive years and the payout ratio is only 35% of cash flow. Rising interest rates will help their bottom line going forward. We continue to recommend a stop loss at $27, looking to achieve $48 -- upside over 25%. Yield 3.0% (Analysts’ price target is $48.36)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly We again reitereate this top retail pharmacy and health care insurance company as a TOP PICK. Sales are up over 8% over the year with net income of $8 billion. It pays a good dividend backed by a payout ratio under 40% of cash flow. We like that it has continued to build cash reserves, while aggressively retiring debt and buying back shares. We recommend moving the stop loss (from $90) down to $85, looking to achieve $117 -- upside potential of 24%. Yield 2.29% (Analysts’ price target is $117.39)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick May 05/22, Up 26.3%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with WEYS has achieved its $30 target. To remain disciplined, we recommend covering half the position at this time and trailing up the stop (from $19.00) to $24.50.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 24/22, Up 13.7%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MRK is progressing well. To remain disciplined, we recommend trailing up the stop (from $80) to $85.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick May 17/22, Up 12.7%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with EOG is progressing well. To remain disciplined, we recommend trailing up the stop (from $105) to $115.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick May 10/22, Up 8.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with LFUS is progressing well. To remain disciplined, we recommend trailing up the stop (from $210) to $230.
COMMENT
Infrastructure: essential daily services delivered to a majority of the population in a "supply-constrained manner". For example, look at Pearson International Airport in Toronto. You can't have two large international airports in one city, so we're seeing bottlenecks at the one infrastructure asset. Likes infrastructure assets that can capture the value of increased foot traffic and not have to engage in price wars.
COMMENT
Airlines. The airlines are having a tough time. They had to downsize during Covid, and then bounce back. The processes are not easy to turn off and on. Most airports are now operating quite efficiently, though there is a range. He doesn't own any. Too much volatility and price competition. He wants to focus on companies that benefit from volumes and don't take price risk.
DON'T BUY
A very concentrated portfolio. For example, CCI is around 11%. Risk is that ETFs don't adjust that much. If there's a downturn, limited ability to be flexible. In contrast SCGI, managed by his firm, has outperformed BGI.UN since inception and can be nimble.
BUY
Risk is that ETFs don't adjust that much. If there's a downturn, limited ability to be flexible. In contrast SCGI, managed by his firm, has outperformed BGI.UN since inception and can be nimble.
BUY
Undervalued, due to small-cap nature and refinery exposure. Really good run this last few weeks. Growth pipeline, possible doubling of EBITDA in 5-10 years. Built out renewables and midstream opportunities. He also owns the spinoff, LCFS, with its flagship renewable diesel project coming online next year.
HOLD
Flagship renewable diesel project coming online next year.
BUY ON WEAKNESS
His preferred name in the space, but currently underweight. Last year, lots of excitement around infrastructure plans. But now concerns about economic slowdown. Best in class. Excellent job of executing on accretive M&A. Not a bad entry point, but be prepared for volatility next 12-18 months.
DON'T BUY
Terrific run on the back of energy rebound. Fairly valued. Historically, leverage up the balance sheet during good times, and then cut dividends and restructure during bad. He prefers Canadian mid-streams, like PPL or GEI, both of which are focused on cashflow. Both are approaching fair value, but are good candidates if your quest is a good dividend and dividend growth.